| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |